Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 1, 2026 21:23 UTC |
Elazzouzi AmySVP, Finance & PAO
|
GrantStock Option (Right to Buy) · Derivative | 46,460 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0002042910-26-000003 · form4-09012026_090904.xml · derivative · entry 2 Elazzouzi Amy · CIK 0002042910 · SVP, Finance & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,460 Underlying: Common Stock · 46,460 shares Expires 2036-09-01 F2 · derivative.exercise_date: The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:23 UTC |
Elazzouzi AmySVP, Finance & PAO
|
GrantCommon Stock | 23,540 | $0.00 | $0.00 |
DisclosureSEC source: 0002042910-26-000003 · form4-09012026_090904.xml · nonDerivative · entry 1 Elazzouzi Amy · CIK 0002042910 · SVP, Finance & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,600 F1 · shares: The reported transaction represents a grant of restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:28 UTC |
Person JulieChief People Officer
|
GrantStock Option (Right to Buy) · Derivative | 212,389 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0001946505-26-000009 · form4-09012026_090914.xml · derivative · entry 2 Person Julie · CIK 0001946505 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,389 Underlying: Common Stock · 212,389 shares Expires 2036-09-01 F2 · derivative.exercise_date: The option shall vest as follows: 25% of the options vest on August 12, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:28 UTC |
Person JulieChief People Officer
|
GrantCommon Stock | 107,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001946505-26-000009 · form4-09012026_090914.xml · nonDerivative · entry 1 Person Julie · CIK 0001946505 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,611 F1 · shares: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:26 UTC |
Kratz EricaChief Reg. & Quality Officer
|
GrantStock Option (Right to Buy) · Derivative | 199,115 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0002148785-26-000009 · form4-09012026_090933.xml · derivative · entry 2 Kratz Erica · CIK 0002148785 · Chief Reg. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,115 Underlying: Common Stock · 199,115 shares Expires 2036-09-01 F2 · derivative.exercise_date: The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:26 UTC |
Kratz EricaChief Reg. & Quality Officer
|
GrantCommon Stock | 100,885 | $0.00 | $0.00 |
DisclosureSEC source: 0002148785-26-000009 · form4-09012026_090933.xml · nonDerivative · entry 1 Kratz Erica · CIK 0002148785 · Chief Reg. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,885 F1 · shares: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:24 UTC |
Hopkins Janet JillChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 116,150 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0001997710-26-000004 · form4-09012026_090929.xml · derivative · entry 2 Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,150 Underlying: Common Stock · 116,150 shares Expires 2036-09-01 F2 · derivative.exercise_date: The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:24 UTC |
Hopkins Janet JillChief Medical Officer
|
GrantCommon Stock | 58,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001997710-26-000004 · form4-09012026_090929.xml · nonDerivative · entry 1 Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,190 F1 · shares: The reported transaction represents a grant of restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:21 UTC |
Abu-Absi SusanChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 265,487 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0002148701-26-000008 · form4-09012026_090941.xml · derivative · entry 2 Abu-Absi Susan · CIK 0002148701 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,487 Underlying: Common Stock · 265,487 shares Expires 2036-09-01 F2 · derivative.exercise_date: The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:21 UTC |
Abu-Absi SusanChief Operating Officer
|
GrantCommon Stock | 134,513 | $0.00 | $0.00 |
DisclosureSEC source: 0002148701-26-000008 · form4-09012026_090941.xml · nonDerivative · entry 1 Abu-Absi Susan · CIK 0002148701 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,513 F1 · shares: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027. Read SEC document |
| July 07, 2026 Filed Jul 8, 2026 20:11 UTC |
Bender JeremyDirector
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001193125-26-298542 · ownership.xml · derivative · entry 2 Bender Jeremy · CIK 0001863107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2036-07-07 F2 · derivative.exercise_date: The shares underlying this option vest in three substantially equal annual installments beginning on July 7, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| July 07, 2026 Filed Jul 8, 2026 20:11 UTC |
Bender JeremyDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-298542 · ownership.xml · nonDerivative · entry 1 Bender Jeremy · CIK 0001863107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in three substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 20:35 UTC |
Kilroy ConorSee Remarks
|
GrantCommon Stock | 14,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-292685 · ownership.xml · nonDerivative · entry 1 Kilroy Conor · CIK 0001808510 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,693 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in two substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC |
Gibney Anthony SSee Remarks
|
SaleCommon Stock | 12,824 | $6.42 | $82,330.08 |
DisclosureSEC source: 0001193125-26-272703 · ownership.xml · nonDerivative · entry 1 Gibney Anthony S · CIK 0001750132 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,354 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC |
Johnson David MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001193125-26-271168 · ownership.xml · derivative · entry 5 Johnson David Michael · CIK 0001808098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-11 F5 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC |
Johnson David MichaelDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-271168 · ownership.xml · nonDerivative · entry 1 Johnson David Michael · CIK 0001808098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,167 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC |
Mattessich Antony C.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001193125-26-271165 · ownership.xml · derivative · entry 2 Mattessich Antony C. · CIK 0001709900 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-11 F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC |
Mattessich Antony C.Director
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-271165 · ownership.xml · nonDerivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,500 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:31 UTC |
Bitetti Teresa MarieDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001193125-26-271171 · ownership.xml · derivative · entry 2 Bitetti Teresa Marie · CIK 0001977608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-11 F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:31 UTC |
Bitetti Teresa MarieDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-271171 · ownership.xml · nonDerivative · entry 1 Bitetti Teresa Marie · CIK 0001977608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,000 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC |
Srivastava SapnaDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001193125-26-271170 · ownership.xml · derivative · entry 2 Srivastava Sapna · CIK 0001569226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-11 F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:30 UTC |
Srivastava SapnaDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-271170 · ownership.xml · nonDerivative · entry 1 Srivastava Sapna · CIK 0001569226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,500 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. Read SEC document |
| May 19, 2026 Filed May 19, 2026 20:59 UTC |
Holles Natalie C.Director · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 2,169,103 | $0.00 Strike: $7.39 | $0.00 |
DisclosureSEC source: 0001580111-26-000009 · ownership.xml · derivative · entry 3 Holles Natalie C. · CIK 0001580111 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,169,103 Underlying: Common Stock · 2,169,103 shares Expires 2036-05-19 F3 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on April 30, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| May 19, 2026 Filed May 19, 2026 20:59 UTC |
Holles Natalie C.Director · See Remarks
|
GrantCommon Stock | 553,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001580111-26-000009 · ownership.xml · nonDerivative · entry 2 Holles Natalie C. · CIK 0001580111 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,153,962 F2 · shares: These shares were acquired pursuant to a performance RSU ("PRSU") award as Inducement Awards. The PRSUs are subject to both time-based vesting and the achievement of a performance condition, both of which must be satisfied before the PRSUs will be deemed vested. The PRSUs shall vest in four substantially equal annual installments commencing on April 15, 2027, subject to Ms. Holles' continued service as of each such time-based vesting date and the satisfaction of the performance condition. The expiration date of the PRSUs is the earlier of (i) the sixth (6th) anniversary of the grant date and (ii) the date Ms. Holles no longer has a service relationship with the Issuer. Any such PRSUs that have not vested on or prior to such expiration date shall be forfeited for no consideration. Read SEC document |
| May 19, 2026 Filed May 19, 2026 20:59 UTC |
Holles Natalie C.Director · See Remarks
|
GrantCommon Stock | 600,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001580111-26-000009 · ownership.xml · nonDerivative · entry 1 Holles Natalie C. · CIK 0001580111 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,118 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award as Inducement Awards. Each RSU represents the right to receive one share of the Issuer's common stock. These RSUs vest in four substantially equal annual installments beginning on April 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:16 UTC |
GOEL DAVID E.10% owner
|
SaleCommon Stock, par value $0.00001 per share (Common Stock) | 6,922,870 | $5.64 | $39,044,986.80 |
DisclosureSEC source: 0000950142-26-001346 · es260777872_4-matrix.xml · nonDerivative · entry 1 Matrix Capital Management Company, LP · CIK 0001410830 · 10% owner GOEL DAVID E. · CIK 0001548144 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · ownership.nature: The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager. F2 · ownership.nature: The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. Read SEC document |
| April 16, 2026 Filed Apr 16, 2026 22:49 UTC |
Kilroy ConorSee Remarks
|
SaleCommon Stock | 11,738 | $7.02 | $82,400.76 |
DisclosureSEC source: 0001193125-26-159579 · ownership.xml · nonDerivative · entry 1 Kilroy Conor · CIK 0001808510 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,835 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.02 to $7.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:06 UTC |
Kilroy ConorSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 112,661 | $0.00 Strike: $6.14 | $0.00 |
DisclosureSEC source: 0001193125-26-088170 · ownership.xml · derivative · entry 2 Kilroy Conor · CIK 0001808510 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,661 Underlying: Common Stock · 112,661 shares Expires 2036-03-02 F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:06 UTC |
Kilroy ConorSee Remarks
|
GrantCommon Stock | 62,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088170 · ownership.xml · nonDerivative · entry 1 Kilroy Conor · CIK 0001808510 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,573 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:05 UTC |
Elazzouzi AmySenior Vice President, Finance
|
GrantStock Option (Right to Buy) · Derivative | 80,472 | $0.00 Strike: $6.14 | $0.00 |
DisclosureSEC source: 0001193125-26-088150 · ownership.xml · derivative · entry 2 Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,472 Underlying: Common Stock · 80,472 shares Expires 2036-03-02 F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:05 UTC |
Elazzouzi AmySenior Vice President, Finance
|
GrantCommon Stock | 44,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088150 · ownership.xml · nonDerivative · entry 1 Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,060 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:06 UTC |
de los Pinos ElisabetDirector · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 249,000 | $0.00 Strike: $6.14 | $0.00 |
DisclosureSEC source: 0001193125-26-088162 · ownership.xml · derivative · entry 3 de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,000 Underlying: Common Stock · 249,000 shares Expires 2036-03-02 F3 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 16:06 UTC |
de los Pinos ElisabetDirector · See Remarks
|
GrantCommon Stock | 166,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088162 · ownership.xml · nonDerivative · entry 1 de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 575,815 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:06 UTC |
Gibney Anthony SSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 128,755 | $0.00 Strike: $6.14 | $0.00 |
DisclosureSEC source: 0001193125-26-088168 · ownership.xml · derivative · entry 2 Gibney Anthony S · CIK 0001750132 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,755 Underlying: Common Stock · 128,755 shares Expires 2036-03-02 F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:06 UTC |
Gibney Anthony SSee Remarks
|
GrantCommon Stock | 71,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088168 · ownership.xml · nonDerivative · entry 1 Gibney Anthony S · CIK 0001750132 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,178 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:05 UTC |
Plavsic MarkChief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 112,661 | $0.00 Strike: $6.14 | $0.00 |
DisclosureSEC source: 0001193125-26-088158 · ownership.xml · derivative · entry 2 Plavsic Mark · CIK 0001868719 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,661 Underlying: Common Stock · 112,661 shares Expires 2036-03-02 F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:05 UTC |
Plavsic MarkChief Technology Officer
|
GrantCommon Stock | 62,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088158 · ownership.xml · nonDerivative · entry 1 Plavsic Mark · CIK 0001868719 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,736 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:05 UTC |
Hopkins Janet JillChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 160,944 | $0.00 Strike: $6.14 | $0.00 |
DisclosureSEC source: 0001193125-26-088154 · ownership.xml · derivative · entry 2 Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,944 Underlying: Common Stock · 160,944 shares Expires 2036-03-02 F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:05 UTC |
Hopkins Janet JillChief Medical Officer
|
GrantCommon Stock | 89,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088154 · ownership.xml · nonDerivative · entry 1 Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,340 F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 00:48 UTC |
Kilroy ConorSee Remarks
|
SaleCommon Stock | 12,079 | $5.05 | $60,998.95 |
DisclosureSEC source: 0001193125-26-055499 · ownership.xml · nonDerivative · entry 1 Kilroy Conor · CIK 0001808510 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,234 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 00:47 UTC |
Elazzouzi AmySenior Vice President, Finance
|
SaleCommon Stock | 8,549 | $5.06 | $43,257.94 |
DisclosureSEC source: 0001193125-26-055494 · ownership.xml · nonDerivative · entry 1 Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,532 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 17, 2026 19:46 UTC |
de los Pinos ElisabetDirector · See Remarks
|
SaleCommon Stock | 47,648 | $5.06 | $241,098.88 |
DisclosureSEC source: 0001193125-26-055487 · ownership.xml · nonDerivative · entry 1 de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,815 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 00:47 UTC |
Plavsic MarkChief Technology Officer
|
SaleCommon Stock | 15,890 | $5.05 | $80,244.50 |
DisclosureSEC source: 0001193125-26-055497 · ownership.xml · nonDerivative · entry 1 Plavsic Mark · CIK 0001868719 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,397 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 00:47 UTC |
Hopkins Janet JillChief Medical Officer
|
SaleCommon Stock | 20,401 | $5.06 | $103,229.06 |
DisclosureSEC source: 0001193125-26-055496 · ownership.xml · nonDerivative · entry 1 Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,284 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 23:41 UTC |
Elazzouzi AmySenior Vice President, Finance
|
SaleCommon Stock | 1,581 | $4.86 | $7,683.66 |
DisclosureSEC source: 0001193125-26-016939 · ownership.xml · nonDerivative · entry 1 Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,081 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 18:41 UTC |
de los Pinos ElisabetDirector · See Remarks
|
SaleCommon Stock | 16,928 | $4.86 | $82,270.08 |
DisclosureSEC source: 0001193125-26-016938 · ownership.xml · nonDerivative · entry 1 de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,463 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 17, 2025 22:56 UTC |
Hopkins Janet JillChief Medical Officer
|
SaleCommon Stock | 17,109 | $5.42 | $92,730.78 |
DisclosureSEC source: 0001193125-25-284878 · ownership.xml · nonDerivative · entry 1 Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,685 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.42 to $5.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 29, 2025 Filed Oct 29, 2025 21:05 UTC |
Elazzouzi AmySenior Vice President, Finance
|
SaleCommon Stock | 896 | $6.35 | $5,689.60 |
DisclosureSEC source: 0001193125-25-256620 · ownership.xml · nonDerivative · entry 1 Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,662 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| October 29, 2025 Filed Oct 29, 2025 17:05 UTC |
de los Pinos ElisabetDirector · See Remarks
|
SaleCommon Stock | 9,049 | $6.35 | $57,461.15 |
DisclosureSEC source: 0001193125-25-256619 · ownership.xml · nonDerivative · entry 1 de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,391 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| October 16, 2025 Filed Oct 16, 2025 21:44 UTC |
Plavsic MarkChief Technology Officer
|
SaleCommon Stock | 12,169 | $6.35 | $77,273.15 |
DisclosureSEC source: 0001193125-25-241622 · ownership.xml · nonDerivative · entry 1 Plavsic Mark · CIK 0001868719 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,287 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.